165 related articles for article (PubMed ID: 38527998)
1. Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.
Uechi L; Vasudevan S; Vilenski D; Branciamore S; Frankhouser D; O'Meally D; Meshinchi S; Marcucci G; Kuo YH; Rockne R; Kravchenko-Balasha N
NPJ Syst Biol Appl; 2024 Mar; 10(1):32. PubMed ID: 38527998
[TBL] [Abstract][Full Text] [Related]
2. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
[TBL] [Abstract][Full Text] [Related]
4. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
5. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.
Jiang F; Mao Y; Lu B; Zhou G; Wang J
Sci Rep; 2021 Jul; 11(1):14657. PubMed ID: 34282207
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
[TBL] [Abstract][Full Text] [Related]
7. Dynamic patterns of microRNA expression during acute myeloid leukemia state-transition.
Frankhouser DE; O'Meally D; Branciamore S; Uechi L; Zhang L; Chen YC; Li M; Qin H; Wu X; Carlesso N; Marcucci G; Rockne RC; Kuo YH
Sci Adv; 2022 Apr; 8(16):eabj1664. PubMed ID: 35452289
[TBL] [Abstract][Full Text] [Related]
8. Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
Cao L; Xiao PF; Tao YF; Hu SY; Lu J; Zhao WL; Li ZH; Wang NN; Wang J; Feng X; Chai YH; Pan J; Gu GX
Oncol Rep; 2016 Feb; 35(2):757-70. PubMed ID: 26573779
[TBL] [Abstract][Full Text] [Related]
9. Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis.
Colombo AR; Triche T; Ramsingh G
Sci Rep; 2018 Nov; 8(1):16449. PubMed ID: 30401833
[TBL] [Abstract][Full Text] [Related]
10. Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.
Marjanovic I; Karan-Djurasevic T; Ugrin M; Virijevic M; Vidovic A; Tomin D; Suvajdzic Vukovic N; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):312-319. PubMed ID: 28163010
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Transcriptome Profiling of Cryptic
Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
[TBL] [Abstract][Full Text] [Related]
12. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells.
Petrov I; Suntsova M; Mutorova O; Sorokin M; Garazha A; Ilnitskaya E; Spirin P; Larin S; Kovalchuk O; Prassolov V; Zhavoronkov A; Roumiantsev A; Buzdin A
Aging (Albany NY); 2016 Nov; 8(11):2936-2947. PubMed ID: 27870639
[TBL] [Abstract][Full Text] [Related]
14. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
[TBL] [Abstract][Full Text] [Related]
15. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
[TBL] [Abstract][Full Text] [Related]
16. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
Zhang Q; Han Q; Zi J; Song C; Ge Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
[TBL] [Abstract][Full Text] [Related]
17. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
[TBL] [Abstract][Full Text] [Related]
18. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
Jin P; Tan Y; Zhang W; Li J; Wang K
Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
20. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
